Prolung Inc Quick Ratio (FRES) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Prolung Inc   (FRES)

Prolung Inc 's Quick Ratio

FRES's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Prolung Inc 's Cash & cash equivalent grew by 184.03 % in the Q1 2023 sequentially, faster than Current Liabilities, this led to improvement in Prolung Inc 's Quick Ratio to 0.06, Quick Ratio remained below Prolung Inc average.

Within Medical Equipment & Supplies industry 231 other companies have achieved higher Quick Ratio than Prolung Inc in first quarter 2023. While Quick Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 4952 to 5067.

Explain Quick Ratio?
How much Cash & cash equivalents FRES´s has?
What are FRES´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FRES Quick Ratio (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1
Y / Y Current Liabilities Change 635.97 % 8.57 % 9.38 % -81.24 % -82.96 %
Y / Y Cash & cash equivalent Change -32.75 % -60.2 % -36.05 % -19.24 % -39.3 %
Quick Ratio MRQ 0.06 0.02 0.06 0.57 0.63
FRES's Total Ranking # 5067 # 4952 # 4414 # 2658 # 2676
Seq. Current Liabilities Change 8.32 % 1.95 % 497.67 % 11.5 % -84.02 %
Seq. Cash & cash equivalent Change 184.03 % -59.53 % -42.32 % 1.45 % 68.07 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 232
Healthcare Sector # 1170
Overall Market # 5067


Quick Ratio Statistics
High Average Low
11.48 1.2 0
(Jun 30 2017)   (Dec 31 2014)




Financial Statements
Prolung Inc 's Current Liabilities $ 15 Millions Visit FRES's Balance sheet
Prolung Inc 's Cash & cash equivalent $ 1 Millions Visit FRES's Balance sheet
Source of FRES's Sales Visit FRES's Sales by Geography


Cumulative Prolung Inc 's Quick Ratio

FRES's Quick Ratio for the trailling 12 Months

FRES Quick Ratio

 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 13.67 % -35.55 % -19.18 % 4.39 % 109.34 %
Y / Y Cash & cash equivalent TTM Growth -33.38 % -35.73 % -19.46 % 8.13 % 48.65 %
Quick Ratio TTM 0.07 0.11 0.13 0.15 0.12
Total Ranking TTM # 4651 # 4654 # 4646 # 4648 # 4640
Seq. Current Liabilities TTM Growth 40.84 % 3.57 % 3.95 % -25.03 % -20.15 %
Seq. Cash & cash equivalent TTM Growth -11.54 % -11.21 % -9.36 % -6.42 % -14.67 %

Quick ratio ranking by company, industry and sector >> Back to FRES Financial Strength Comparisons >> Go to Compare FRES Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q1 2023 to $14.62 millions, cumulative Quick Ratio decreased to 0.07 below the Prolung Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 253 other companies have achieved higher Quick Ratio than Prolung Inc . While Quick Ratio overall ranking has improved so far to 4651, from total ranking during the twelve months ending fourth quarter 2022 at 4654.

Explain Quick Ratio?
How much Cash & cash equivalents FRES´s has?
What are FRES´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 254
Healthcare Sector # 1193
Within the Market # 4651


trailing twelve months Quick Ratio Statistics
High Average Low
6.02 1.17 0.06
(Dec 31 2017)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Premier Air Charter Holdings Inc   0.16 $ 0.029  Millions$ 0.183  Millions
Mountain Crest Acquisition Corp V  0.15 $ 0.123  Millions$ 0.820  Millions
Patterson Companies Inc   0.15 $ 159.669  Millions$ 1,085.332  Millions
Zimmer Biomet Holdings Inc   0.14 $ 330.200  Millions$ 2,335.900  Millions
Boston Scientific Corporation  0.14 $ 570.000  Millions$ 4,083.000  Millions
The Cooper Companies Inc   0.13 $ 111.900  Millions$ 829.400  Millions
Ufp Technologies Inc   0.12 $ 6.503  Millions$ 52.192  Millions
Stevanato Group S p a   0.12 $ 77.954  Millions$ 643.315  Millions
Sigyn Therapeutics Inc   0.12 $ 0.322  Millions$ 2.778  Millions
Legacy Ventures International Inc  0.11 $ 0.002  Millions$ 0.018  Millions
Biotricity Inc   0.10 $ 1.159  Millions$ 11.161  Millions
Precision Optics Corporation Inc   0.09 $ 0.612  Millions$ 6.495  Millions
Seastar Medical Holding Corp  0.09 $ 0.725  Millions$ 8.036  Millions
Ss Innovations International Inc  0.09 $ 0.449  Millions$ 5.119  Millions
Dynatronics Corporation  0.07 $ 0.517  Millions$ 6.978  Millions
Assure Holdings Corp   0.07 $ 0.505  Millions$ 7.201  Millions
Enovis Corp  0.06 $ 21.900  Millions$ 349.497  Millions
Henry Schein Inc   0.06 $ 126.000  Millions$ 2,099.000  Millions
Prolung Inc   0.06 $ 0.842  Millions$ 14.624  Millions
Euda Health Holdings Limited  0.06 $ 0.837  Millions$ 14.546  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.06 $ 0.356  Millions$ 6.405  Millions
Yubo International Biotech Limited  0.05 $ 0.124  Millions$ 2.285  Millions
Qhslab Inc   0.05 $ 0.093  Millions$ 1.811  Millions
Bioplus Acquisition Corp   0.05 $ 0.035  Millions$ 0.701  Millions
The Pennant Group Inc   0.04 $ 2.952  Millions$ 65.628  Millions
Marizyme Inc   0.04 $ 0.360  Millions$ 8.027  Millions
Achari Ventures Holdings Corp I  0.04 $ 0.081  Millions$ 2.125  Millions
Trisalus Life Sciences Inc   0.03 $ 0.137  Millions$ 4.664  Millions
Non Invasive Monitoring Systems Inc  0.03 $ 0.018  Millions$ 0.617  Millions
P3 Health Partners Inc   0.03 $ 7.183  Millions$ 269.661  Millions

Date modified: 2026-09-08T15:10:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.